The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$ ...

The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$ 6.33 Billion in 2024 and an impressive US$ 9.62 Billion by 2030. The ...

The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$ 6.33 Billion in ...

Nearly seven million Americans live with Alzheimer’s disease, a progressive condition that destroys memory and other mental ...

Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

Palestinians will mark this year the 77th anniversary of their mass expulsion from what is now Israel, an event that is at the core of their national ...

After a violent year that saw multiple mass shootings in the state, Alabama Gov. Kay Ivey and many lawmakers in both parties ...

Introduction to Newborn Screening InstrumentsNewborn screening is a critical medical process that involves testing newborns for certain genetic, metabolic, and congenital conditions. The objective is ...

Researchers found that moderate triclosan exposure is significantly linked to increased breast cancer risk, particularly in ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

The IM-2 mission will test lunar mobility, resource prospecting and the first-ever cellular network on the moon.